Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2

被引:12
作者
Parums, Dinah V. [1 ]
机构
[1] Int Sci Informat Inc, Med Sci Monitor, Melville, NY 11747 USA
来源
MEDICAL SCIENCE MONITOR | 2022年 / 28卷
关键词
SCIENTISTS;
D O I
10.12659/MSM.936199
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The omicron variant of SARS-CoV-2, B.1.1.529, was included in the World Health Organization (WHO) list of variants of concerns (VOC) on 26 November 2021. Within only three months, omicron has spread rapidly to become the dominant variant in many countries. Studies have begun to evaluate the virulence, transmissibility, and degree of immune protection from current SARS-CoV-2 vaccines or previous of infection with the omicron variant. On 21 January 2022, the WHO published its seventh technical update and recommendations for priority actions in response to the omicron SARS-CoV-2 variant and cautioned that the overall risk from omicron remains high. At the start of this third year of the global COVID-19 pandemic, this editorial aims to summarize the evidence that supports the current priority recommendations and response from the WHO regarding the omicron variant of SARS-CoV-2, B.1.1.529. © Med Sci Monit, 2022.
引用
收藏
页数:3
相关论文
共 21 条
[11]   The omicron variant of SARS-CoV-2: Understanding the known and living with unknowns COMMENT [J].
Ingraham, Nicholas E. ;
Ingbar, David H. .
CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (12)
[12]   SARS-CoV-2 Variants, Vaccines, and Host Immunity [J].
Mistry, Priyal ;
Barmania, Fatima ;
Mellet, Juanita ;
Peta, Kimberly ;
Strydom, Adele ;
Viljoen, Ignatius M. ;
James, William ;
Gordon, Siamon ;
Pepper, Michael S. .
FRONTIERS IN IMMUNOLOGY, 2022, 12
[13]  
Netzl A, BIORXIV, DOI [10.1101/2021.12.31.474032v1.full.pdf, DOI 10.1101/2021.12.31.474032V1.FULL.PDF]
[14]   Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2 [J].
Parums, Dinah V. .
MEDICAL SCIENCE MONITOR, 2021, 27
[15]   Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron [J].
Shuai, Huiping ;
Chan, Jasper Fuk-Woo ;
Hu, Bingjie ;
Chai, Yue ;
Yuen, Terrence Tsz-Tai ;
Yin, Feifei ;
Huang, Xiner ;
Yoon, Chaemin ;
Jing-Chu Hu ;
Liu, Huan ;
Shi, Jialu ;
Liu, Yuanchen ;
Zhu, Tianrenzheng ;
Zhang, Jinjin ;
Hou, Yuxin ;
Wang, Yixin ;
Lu, Lu ;
Jian-Piao Cai ;
Zhang, Anna Jinxia ;
Zhou, Jie ;
Yuan, Shuofeng ;
Brindley, Melinda A. ;
Bao-Zhong Zhang ;
Jian-Dong Huang ;
To, Kelvin Kai-Wang ;
Kwok-Yung Yuen ;
Chu, Hin .
NATURE, 2022, 603 (7902) :693-+
[16]  
UK Health Security Agency, 2021, SARS COV 2 VAR VAR I
[17]   Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2 [J].
Vogels, Chantal B. F. ;
Breban, Mallery I. ;
Ott, Isabel M. ;
Alpert, Tara ;
Petrone, Mary E. ;
Watkins, Anne E. ;
Kalinich, Chaney C. ;
Earnest, Rebecca ;
Rothman, Jessica E. ;
de Jesus, Jaqueline Goes ;
Claro, Ingra Morales ;
Ferreira, Giulia Magalhaes ;
Crispim, Myuki A. E. ;
Singh, Lavanya ;
Tegally, Houriiyah ;
Anyaneji, Ugochukwu J. ;
Hodcroft, Emma B. ;
Mason, Christopher E. ;
Khullar, Gaurav ;
Metti, Jessica ;
Dudley, Joel T. ;
MacKay, Matthew J. ;
Nash, Megan ;
Wang, Jianhui ;
Liu, Chen ;
Hui, Pei ;
Murphy, Steven ;
Neal, Caleb ;
Laszlo, Eva ;
Landry, Marie L. ;
Muyombwe, Anthony ;
Downing, Randy ;
Razeq, Jafar ;
de Oliveira, Tulio ;
Faria, Nuno R. ;
Sabino, Ester C. ;
Neher, Richard A. ;
Fauver, Joseph R. ;
Grubaugh, Nathan D. .
PLOS BIOLOGY, 2021, 19 (05)
[18]  
WHO, 2022, Enhancing response to Omicron SARS-CoV-2 variant: Technical brief and priority actions for Member States'
[19]  
World Health Organization, 2022, SARS-CoV-2 Omicron variant assays and animal models study tracker
[20]  
World Health Organization, 2022, Tracking SARS-CoV-2 variants